We are live on ! Find out more
TIL icon

Instil Bio

Fund managers haven’t disclosed any holdings of TIL yet.

TIL Hedge Fund Activity: Q1 2026 in Review

32 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q1 2026, worth a combined $34.6M — down 29% from $48.9M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TIL positions and 6 closed out — a net gain of 4 holders — while 4 added to existing stakes and 8 trimmed.

The largest buyer was Kalehua Capital Management, opening a new position worth an estimated $1.48M. The largest seller was Siren LLC, exiting entirely with an estimated $2.24M sold.

  • 32 institutional investors held Instil Bio (TIL) as of Q1 2026, up from 29 in Q4 2025.
  • Funds reported $34.6M of Instil Bio stock for Q1 2026, down 29% quarter-over-quarter.
  • 10 funds opened new Instil Bio positions in Q1 2026 and 6 closed out, a net change of +4 holders.
  • The largest Instil Bio buyer in Q1 2026 was Kalehua Capital Management, an estimated $1.48M added.
  • The largest Instil Bio seller in Q1 2026 was Siren LLC, an estimated $2.24M sold.

Based on aggregated 13F filings for Q1 2026.